David R Tribble1, Clinton K Murray2,3, Bradley A Lloyd4,5, Anuradha Ganesan1,6,7, Katrin Mende1,2,7, Dana M Blyth2, Joseph L Petfield4, Jay McDonald8,9. 1. Infectious Disease Clinical Research Program, Preventive Medicine & Biostatistics Department, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814. 2. Brooke Army Medical Center, 3551 Roger Brooke Drive, JBSA Fort Sam Houston, TX 78234. 3. Current affiliation is 1st Area Medical Laboratory, Aberdeen Proving Ground, MD. 4. Landstuhl Regional Medical Center, Landstuhl, Germany, CMR 402, APO, AE, 09180. 5. Current affiliation is Wright Patterson Medical Center, OH. 6. Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD 20852. 7. Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720 A Rockledge Drive, Bethesda, MD 20817. 8. Veterans Affairs St. Louis Health Care System, 915 N Grand Blvd, St. Louis, MO 63106. 9. Washington University School of Medicine, 660 Euclid Ave, St. Louis, MO 63110.
Abstract
INTRODUCTION: During recent wars in Iraq and Afghanistan, improved survivability in severe trauma corresponded with a rise in the proportion of trauma-related infections, including those associated with multidrug-resistant organisms (MDROs). Significant morbidity was reported in association with the infections. There is also concern regarding potential long-term impacts of the trauma-related infectious complications. Therefore, to meet the critical need of prospective collection of standardized infection-related data to understand the disease burden and improve outcomes of wounded personnel, the Trauma Infectious Disease Outcomes Study (TIDOS) was developed. Herein, we review accomplishments and key peer-reviewed findings of TIDOS. METHODS: The TIDOS project is a multicenter observational study of short- and long-term infectious complications following deployment-related trauma. Wounded military personnel medevac'd to Landstuhl Regional Medical Center (LRMC; Germany) before transfer to a participating US military hospital between June 2009 and December 2014 were eligible for inclusion. An infectious disease module to supplement the Department of Defense Trauma Registry by collecting infection-related data from all trauma patients admitted to participating hospitals was developed. Specimens from trauma patients were also collected and retained in a microbiological isolate repository. During the initial hospitalization, patients were given the opportunity to enroll in a prospective follow-up cohort study. Patients who received Department of Veterans Affairs (VA) care were also given the opportunity to consent to ongoing VA follow-up. RESULTS: A total of 2,699 patients transferred to participating military hospitals in the USA, of which 1,359 (50%) patients enrolled in the TIDOS follow-up cohort. In addition, 638 enrolled in the TIDOS-VA cohort (52% of TIDOS enrollees who entered VA healthcare). More than 8,000 isolates were collected from infection control surveillance and diagnostic evaluations and retained in the TIDOS Microbiological Repository. Approximately 34% of the 2,699 patients at US hospitals developed a trauma-related infection during their initial hospitalization with skin and soft-tissue infections being predominant. After discharge from the US hospitals, approximately one-third of TIDOS cohort enrollees developed a new trauma-related infection during follow-up and extremity wound infections (skin and soft-tissue infections and osteomyelitis) continued to be the majority. Among TIDOS cohort enrollees who received VA healthcare, 38% developed a new trauma-related infection with the incident infection being diagnosed a median of 88 days (interquartile range: 19-351 days) following hospital discharge. Data from TIDOS have been used to support the development of Joint Trauma System clinical practice guidelines for the prevention of combat-related infections, as well as the management of invasive fungal wound infections. Lastly, due to the increasing proportion of infections associated with MDROs, TIDOS investigators have collaborated with investigators across military laboratories as part of the Multidrug-Resistant and Virulent Organisms Trauma Infections Initiative with the objective of improving the understanding of the complex wound microbiology in order to develop novel infectious disease countermeasures. CONCLUSIONS: The TIDOS project has focused research on four initiatives: (1) blast-related wound infection epidemiology and clinical management; (2) DoD-VA outcomes research; (3) Multidrug- Resistant and other Virulent Organisms Trauma Infections Initiative; and (4) Joint Trauma System clinical practice guidelines and antibiotic stewardship. There is a continuing need for longitudinal data platforms to support battlefield wound research and clinical practice guideline recommendation refinement, particularly to improve care for future conflicts. As such, maintaining a research platform, such as TIDOS, would negate the lengthy time needed to initiate data collection and analysis. Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2019. This work is written by (a) US Government employee(s) and is in the public domain in the US.
INTRODUCTION: During recent wars in Iraq and Afghanistan, improved survivability in severe trauma corresponded with a rise in the proportion of trauma-related infections, including those associated with multidrug-resistant organisms (MDROs). Significant morbidity was reported in association with the infections. There is also concern regarding potential long-term impacts of the trauma-related infectious complications. Therefore, to meet the critical need of prospective collection of standardized infection-related data to understand the disease burden and improve outcomes of wounded personnel, the Trauma Infectious Disease Outcomes Study (TIDOS) was developed. Herein, we review accomplishments and key peer-reviewed findings of TIDOS. METHODS: The TIDOS project is a multicenter observational study of short- and long-term infectious complications following deployment-related trauma. Wounded military personnel medevac'd to Landstuhl Regional Medical Center (LRMC; Germany) before transfer to a participating US military hospital between June 2009 and December 2014 were eligible for inclusion. An infectious disease module to supplement the Department of Defense Trauma Registry by collecting infection-related data from all traumapatients admitted to participating hospitals was developed. Specimens from traumapatients were also collected and retained in a microbiological isolate repository. During the initial hospitalization, patients were given the opportunity to enroll in a prospective follow-up cohort study. Patients who received Department of Veterans Affairs (VA) care were also given the opportunity to consent to ongoing VA follow-up. RESULTS: A total of 2,699 patients transferred to participating military hospitals in the USA, of which 1,359 (50%) patients enrolled in the TIDOS follow-up cohort. In addition, 638 enrolled in the TIDOS-VA cohort (52% of TIDOS enrollees who entered VA healthcare). More than 8,000 isolates were collected from infection control surveillance and diagnostic evaluations and retained in the TIDOS Microbiological Repository. Approximately 34% of the 2,699 patients at US hospitals developed a trauma-related infection during their initial hospitalization with skin and soft-tissue infections being predominant. After discharge from the US hospitals, approximately one-third of TIDOS cohort enrollees developed a new trauma-related infection during follow-up and extremity wound infections (skin and soft-tissue infections and osteomyelitis) continued to be the majority. Among TIDOS cohort enrollees who received VA healthcare, 38% developed a new trauma-related infection with the incident infection being diagnosed a median of 88 days (interquartile range: 19-351 days) following hospital discharge. Data from TIDOS have been used to support the development of Joint Trauma System clinical practice guidelines for the prevention of combat-related infections, as well as the management of invasive fungal wound infections. Lastly, due to the increasing proportion of infections associated with MDROs, TIDOS investigators have collaborated with investigators across military laboratories as part of the Multidrug-Resistant and Virulent Organisms Trauma Infections Initiative with the objective of improving the understanding of the complex wound microbiology in order to develop novel infectious disease countermeasures. CONCLUSIONS: The TIDOS project has focused research on four initiatives: (1) blast-related wound infection epidemiology and clinical management; (2) DoD-VA outcomes research; (3) Multidrug- Resistant and other Virulent Organisms Trauma Infections Initiative; and (4) Joint Trauma System clinical practice guidelines and antibiotic stewardship. There is a continuing need for longitudinal data platforms to support battlefield wound research and clinical practice guideline recommendation refinement, particularly to improve care for future conflicts. As such, maintaining a research platform, such as TIDOS, would negate the lengthy time needed to initiate data collection and analysis. Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2019. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Entities:
Keywords:
combat-related infections; military health; trauma-related infections; wound infections
Authors: Bradley Lloyd; Amy C Weintrob; Carlos Rodriguez; James R Dunne; Allison B Weisbrod; Mary Hinkle; Tyler Warkentien; Clinton K Murray; John Oh; Eugene V Millar; Jinesh Shah; Faraz Shaikh; Stacie Gregg; Gina Lloyd; Julie Stevens; M Leigh Carson; Deepak Aggarwal; David R Tribble Journal: Surg Infect (Larchmt) Date: 2014-05-13 Impact factor: 2.150
Authors: Bradley A Lloyd; Clinton K Murray; Faraz Shaikh; M Leigh Carson; Dana M Blyth; Elizabeth R Schnaubelt; Timothy J Whitman; David R Tribble Journal: Mil Med Date: 2018-09-01 Impact factor: 1.437
Authors: Benjamin K Potter; Jonathan A Forsberg; Elizabeth Silvius; Matthew Wagner; Vivek Khatri; Seth A Schobel; Arnaud J Belard; Amy C Weintrob; David R Tribble; Eric A Elster Journal: Mil Med Date: 2019-01-01 Impact factor: 1.437
Authors: Rae A Heitkamp; Ping Li; Katrin Mende; Samandra T Demons; David R Tribble; Stuart D Tyner Journal: Surg Infect (Larchmt) Date: 2017-12-20 Impact factor: 2.150
Authors: Bradley A Lloyd; Clinton K Murray; Faraz Shaikh; M Leigh Carson; Dana M Blyth; Elizabeth R Schnaubelt; Timothy J Whitman; David R Tribble Journal: J Trauma Acute Care Surg Date: 2017-11 Impact factor: 3.313
Authors: David R Tribble; Ping Li; Tyler E Warkentien; Bradley A Lloyd; Elizabeth R Schnaubelt; Anuradha Ganesan; William Bradley; Deepak Aggarwal; M Leigh Carson; Amy C Weintrob; Clinton K Murray Journal: Mil Med Date: 2016-10 Impact factor: 1.437
Authors: Tyler Warkentien; Carlos Rodriguez; Bradley Lloyd; Justin Wells; Amy Weintrob; James R Dunne; Anuradha Ganesan; Ping Li; William Bradley; Lakisha J Gaskins; Françoise Seillier-Moiseiwitsch; Clinton K Murray; Eugene V Millar; Bryan Keenan; Kristopher Paolino; Mark Fleming; Duane R Hospenthal; Glenn W Wortmann; Michael L Landrum; Mark G Kortepeter; David R Tribble Journal: Clin Infect Dis Date: 2012-10-05 Impact factor: 9.079
Authors: Erica N Johnson; Travis C Burns; Roman A Hayda; Duane R Hospenthal; Clinton K Murray Journal: Clin Infect Dis Date: 2007-07-05 Impact factor: 9.079
Authors: Sarah M Heaton; Amy C Weintrob; Kevin Downing; Bryan Keenan; Deepak Aggarwal; Faraz Shaikh; David R Tribble; Justin Wells Journal: BMC Clin Pathol Date: 2016-07-07
Authors: Patrick F Walker; Joseph D Bozzay; David W Schechtman; Faraz Shaikh; Laveta Stewart; M Leigh Carson; David R Tribble; Carlos J Rodriguez; Matthew J Bradley Journal: Am Surg Date: 2022-01-13 Impact factor: 0.688
Authors: Shannon L McCarthy; Laveta Stewart; Faraz Shaikh; Clinton K Murray; David R Tribble; Dana M Blyth Journal: J Intensive Care Med Date: 2022-02-16 Impact factor: 2.889
Authors: Joseph L Petfield; Louis R Lewandowski; Laveta Stewart; Clinton K Murray; David R Tribble Journal: Mil Med Date: 2022-05-04 Impact factor: 1.563
Authors: Katrin Mende; Kevin S Akers; Stuart D Tyner; Jason W Bennett; Mark P Simons; Dana M Blyth; Ping Li; Laveta Stewart; David R Tribble Journal: Mil Med Date: 2022-05-04 Impact factor: 1.563
Authors: David R Tribble; Mary Ann Spott; Stacey A Shackleford; Jennifer M Gurney; Bg Clinton K Murray Journal: Mil Med Date: 2022-05-04 Impact factor: 1.563
Authors: Joseph D Bozzay; Patrick F Walker; David W Schechtman; Faraz Shaikh; Laveta Stewart; David R Tribble; Matthew J Bradley Journal: J Surg Res Date: 2020-08-29 Impact factor: 2.192
Authors: Trivia Frazier; Andrea Alarcon; Xiying Wu; Omair A Mohiuddin; Jessica M Motherwell; Anders H Carlsson; Robert J Christy; Judson V Edwards; Robert T Mackin; Nicolette Prevost; Elena Gloster; Qiang Zhang; Guangdi Wang; Daniel J Hayes; Jeffrey M Gimble Journal: Biomolecules Date: 2020-09-27
Authors: John L Kiley; Katrin Mende; Miriam L Beckius; Susan J Kaiser; M Leigh Carson; Dan Lu; Timothy J Whitman; Joseph L Petfield; David R Tribble; Dana M Blyth Journal: PLoS One Date: 2021-08-02 Impact factor: 3.240